Uterine carcinosarcomas, also known as malignant mixed mullerian tumors, are one of the rare and most aggressive neoplasms of the uterus. They have an aggressive course and can spread to distant organs. Owing to the low incidence of these tumors, the optimal adjuvant management after surgery is not well established. Many patients develop distant metastases during follow-up. An interesting case of uterine carcinosarcoma who developed metastases to the femur, tibia, and calcaneum during follow is presented.
Introduction
Uterine carcinosarcoma is rare malignant tumors of the uterus. They are biphasic tumors with both carcinomatous component and sarcomatous component. Carcinosarcomas can also arise from the skin, salivary glands, lungs, and esophagus. A rare case of uterine carcinosarcoma with peripheral skeletal metastases is presented in this case report.
Case Report
A 56-year-old female, a previously treated case of uterine carcinosarcoma, presented to the oncologist with pain in the right lower limb. She had undergone total abdominal hysterectomy and bilateral salpingo-oophorectomy for uterine carcinosarcoma before 2 years. On evaluation, there was tenderness around the right knee joint and right leg. Radiography showed a lytic lesion in the lateral condyle of the right femur and the proximal tibia. Biopsy from tibia was consistent with metastases from uterine carcinosarcoma. 
Discussion
Uterine sarcomas, also known as malignant mixed mullerian tumors, are rare uterine neoplams constituting <5% of all uterine malignancies. [1] They are known to occur in patients who have received pelvic irradiation. [2] They are also one of the most aggressive neoplasms with dismal prognosis. [3] Due to their monoclonal origin, they are now being considered as a metaplastic carcinoma. [4] The reported incidence of this condition is roughly eight new cases per million women. [5] Surgery is the main line of treatment which includes hysterectomy with or without pelvic lymphadenectomy. No consensus is available as to the appropriate adjuvant This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
For reprints contact: reprints@medknow.com therapy postsurgery. Carcinosarcomas have propensity for transperitoneal spread like high-grade endometrial neoplasm. Metastatic disease to the lungs have also been described. [6] A case of carcinosarcoma metastases to the calcanuem has been previously reported. [7] Acral skeletal metastases are very rare and the most common cancers producing metastases to the peripheral skeleton are lung, renal, and thyroid cancers. [8] Carcinosarcomas should also be considered in the differential diagnosis of patients with acral metastases.
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